Skip to main content
SpringerLink
Log in

Diabetic nephropathy in 2010

Alleviating the burden of diabetic nephropathy

  • Year in Review
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

Many patients with diabetic nephropathy progress to end-stage renal disease. New research in disease detection, diagnosis, and novel treatments will hopefully alleviate the burden of diabetic nephropathy in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Papale, M. et al. Urine proteome analysis may allow non-invasive differential diagnosis of diabetic nephropathy. Diabetes Care 33, 2409–2415 (2010).

    Article  CAS  Google Scholar 

  2. Overgaard, A. J. et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Science 8, 4 (2010).

    Article  Google Scholar 

  3. Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S. & Thornalley, P. J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52, 2110–2120 (2003).

    Article  CAS  Google Scholar 

  4. Alkhalaf, A. et al. A double-blind, randomized, placebo controlled clinical trial on benfotiamine treatment in patietns with diabetic nephropathy. Diabetes Care 33, 1598–1601 (2010).

    Article  CAS  Google Scholar 

  5. Rabbani, N. et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52, 208–212 (2009).

    Article  CAS  Google Scholar 

  6. Ismail-Beigi, F. et al. Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419–430 (2010).

    Article  Google Scholar 

  7. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).

    Article  CAS  Google Scholar 

  8. Zoungas, A. et al. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. Diabetologia 53 (Suppl. 1), S98 (2010).

    Google Scholar 

  9. Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129–139 (2009).

    Article  CAS  Google Scholar 

  10. Tessari, P. et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59, 2152–2159 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetic Complications Laboratory, Baker IDI Heart & Diabetes Institute, 75 Commercial Road, Melbourne, 3004, VIC, Australia

    Stephen P. Gray & Mark E. Cooper

Authors
  1. Stephen P. Gray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen P. Gray.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gray, S., Cooper, M. Alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 7, 71–73 (2011). https://doi.org/10.1038/nrneph.2010.176

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.176

  • Springer Nature Limited

This article is cited by

Search

Navigation